ClinicalTrials.gg
DrugBiological

Belimumab clinical trials

Also written Benlysta, LymphoStat-B™ and HGS1006.

studies test it
77
open now
16
in phase 3
19
first study started
2002

How each study uses belimumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the belimumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Mar 2011 · BENLYSTA · BLA 125370 (FDA, Drugs@FDA)
European Union
13 Jul 2011 · Benlysta · EMEA/H/C/002015 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Belimumab
49
Belimumab 10 mg/kg
7
Belimumab 1 mg/kg
5
Belimumab 10 mg/kg plus standard therapy
3
Belimumab Injection
2

Brand

Benlysta
29
LymphoStat-B™
9

Development codes

HGS1006
3

Studies by the year they started

77 studies that test it; most in 2021 (8)

Studies that test belimumab, by start year
YearStudies
20021
20032
20052
20061
20071
20083
20092
20103
20113
20127
20137
20143
20153
20161
20171
20183
20194
20203
20218
20225
20233
20248
20252
20261

Who runs them

Industry 39 · Other 38

GlaxoSmithKline (22) · Human Genome Sciences Inc., a GSK Company (8) · Human Genome Sciences Inc. (8) · Leiden University Medical Center (3) · Peking Union Medical College Hospital (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Assistance Publique - Hôpitaux de Paris (3) · Hospital for Special Surgery, New York (2)

Often tested with

Tested in the same studies.

Rituximab (6) · Mycophenolic Acid (2) · GSK4527363 (1) · Candida albicans Antigen Injection (1) · Methotrexate (1) · Sulfasalazine (1) · Hydroxychloroquine (1) · Leflunomide (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test belimumab, phase 3 first.

Studies

Open first, then newest update. How each study uses belimumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 77

See all 77 studies that test belimumab →

Given beside what is tested · 1 — belimumab is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with belimumab

Codes

What other systems call belimumab · ClinicalTrials.gg INT004939

  • MeSH (NLM) C511911belimumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 73B0K5S26ABELIMUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1092437Confirmed FDA, Wikidata
  • Wikidata Q1996249belimumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C91385BelimumabOne source FDA
  • DrugBank DB08879One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.